跳至主要内容
临床试验/NCT06650826
NCT06650826招募中不适用

The APIT Study: Prospective Observational Study of the Incidence of Anti-platelet Factor 4 Antibodies in Suspected Immune-associated Arterial and/or Venous Thrombosis

Cardioangiologisches Centrum Bethanien2 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2024年7月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
发起方
入组人数
200
试验地点
2
主要终点
Presence of anti-platelet factor 4 antibodies in temporal connection with the occurrence of arterial and/or venous thrombosis

研究概览

简要总结

Prospective investigation of the incidence of anti-platelet factor 4 antibodies in suspected immune-associated arterial and/or venous thrombosis

详细描述

Patients with venous and/or arterial thrombosis aged 18 to 60 years are included.Thromboses should have occurred spontaneously or within 30 days after an infection or vaccination. In addition, patients with recurrent thrombosis, despite anticoagulation, are also included in the study. The primary aim of the study is to determine the incidence of anti-platelet factor 4 antibodies in relation to venous and/or arterial thrombosis. For this purpose, we will take a blood sample from the patients within 120 days of the occurrence of the thrombosis.

As a secondary objective, platelet count, D-dimer and results of a thrombophilia screening as well as thrombosis localization are recorded.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 60 Years(Adult)
性别
All
接受健康志愿者

入选标准

  • Age between 18-60 years
  • Written informed consent of the patient
  • Spontaneous arterial and/or venous thrombosis
  • infection-associated arterial and/or venous thrombosis within 30 days of infection
  • Vaccine-associated arterial and/or venous thrombosis within 30 days of vaccination
  • Recurrent arterial or venous thrombosis despite anticoagulant therapy

排除标准

  • Lack of consent of the patient
  • Risk-associated venous thromboses (e.g. following surgery, immobilization, plaster cast, fractures or sprains)
  • Risk-associated arterial thromboses (in the presence of vascular risk factors such e.g. diabetes mellitus, hypercholesterolemia, hypertension, nicotine abuse)
  • Thromboses more than 120 days old at the time of blood sampling

结局指标

主要结局

Presence of anti-platelet factor 4 antibodies in temporal connection with the occurrence of arterial and/or venous thrombosis

时间窗: Day 1

Presence of anti-platelet factor 4 antibodies in temporal connection with the occurrence of arterial and/or venous thrombosis

次要结局

未报告次要终点

研究者

发起方
Cardioangiologisches Centrum Bethanien
申办方类型
Other
责任方
Principal Investigator
主要研究者

Prof. Dr. med. E. Lindhoff-Last

Clinical Professor

Cardioangiologisches Centrum Bethanien

研究点 (2)

Loading locations...

相似试验

招募中
不适用
Investigation of prevalence of anti-PF4 antibodies recognizing the binding site of VITT antibodies on PF4 and of anti-PF4/heparin antibodies recognizing the binding site of HIT antibodies in normal individuals and patients referred with the clinical suspicion of either HIT, or VITT, and in patients with thrombosis of unknown causeAnti-PF4-antibody-associated disorders
DRKS00032653niversitätsmedizin Greifswald500
已完成
不适用
An Epidemiological Study of Subjects With Immune Thrombocytopenic Purpura to Evaluate the Relationship Between Platelet Counts, Endogenous Thrombopoietin Levels, Endogenous Anti-Thrombopoietin Antibodies, and Selected Autoimmune MarkersPurpura, Thrombocytopenic, IdiopathicImmune Thrombocytopenic Purpura
NCT00005570National Heart, Lung, and Blood Institute (NHLBI)200
终止
4 期
Significance of Antibodies to Heparin/Platelet Factor 4 Complex in Vein Graft Patency and Potential Role of Argatroban for Prevention of Vein Graft OcclusionCoronary Artery Bypass Graft SurgeryPresence of Heparin/Platelet Factor 4 Antibody
NCT01246011Massachusetts General Hospital9
已完成
不适用
An Observational, Multicenter Study to Evaluate the Use and Effectiveness of Doptelet® in Patients With ITPITPImmune Thrombocytopenia
NCT04943042Swedish Orphan Biovitrum199
进行中(未招募)
4 期
Vaccination Against Human Papillomavirus (HPV) With the 9-valent Vaccine in HIV-positive Women (the Papillon Study)HPV - Anogenital Human Papilloma Virus InfectionHIV Infections
NCT03391921Centre Hospitalier Universitaire Saint Pierre170